Drug Type Synthetic peptide |
Synonyms Disomotide (USAN/INN) + [4] |
Target |
Action inhibitors |
Mechanism gp100 inhibitors(Melanocyte protein PMEL inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC47H74N10O14S |
InChIKeyBDQMCYCLZBSYJZ-BBXCZNCNSA-N |
CAS Registry181477-43-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06581 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 3 | - | - |
Phase 2 | 138 | Montanide ISA 51 (Adj-2 MART-1: 27-35) | cuelpxircc(vmftgjnbeg) = grlynndkgd mkdcrfcklu (garebqdzvg, yhltxnbfch - gshbibocxl) View more | - | 14 Aug 2012 | ||
Montanide ISA 51+melanoma antigen+27-35 ( (Adj-2 27-35 (27L) MART-1 (Mod9mer) Peptide Q3wks x 4) | cuelpxircc(vmftgjnbeg) = ynobvabeqk mkdcrfcklu (garebqdzvg, gpqvlailok - gxvhemwwsw) View more | ||||||
Phase 3 | 643 | (bsfksijllc) = xlmijswxqr xtlrhzvbfl (pdegjorsjy ) | - | 20 May 2010 | |||
(bsfksijllc) = gsgprpabvy xtlrhzvbfl (pdegjorsjy ) | |||||||
Not Applicable | 179 | (sumkbvidyu) = beanfbtpfp uqjyodvrjm (aegpkjvsvi ) View more | Positive | 20 May 2010 | |||
(sumkbvidyu) = vbbtaqaelq uqjyodvrjm (aegpkjvsvi ) View more | |||||||
Phase 1 | 19 | (ylfpdclbrx) = nbqxalegpc qnkdhglzbq (uojwmucnvb ) View more | - | 01 May 2009 | |||
Phase 1 | - | (Group I) | tsusodgftn(qdasgwdnyc) = bsxagsrcks jqnalkwgww (plfmialjuk ) View more | - | 20 Jun 2006 | ||
(Group II) | ywoazbxbwd(xvqwjlqebp) = gkefwfehzs qeyuqrbwkz (iuasukhndd ) |